Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Can the Xpert MRSA/SA BC assay be used as an antimicrobial stewardship tool? A prospective assay validation and descriptive impact assessment study in a South African setting

Fig. 2

Antibiotic progression at Gram stain availability and final culture result availability. CI: confidence interval. a Modification: change from an ineffective to a more effective agent, or the addition of a semisynthetic penicillin (methicillin-susceptible S. aureus) or glycopeptide (methicillin-resistant S. aureus); b De-escalation: change to a narrower-spectrum, targeted antistaphylococcal agent, or cessation of some or all antibiotics

Back to article page